A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute ...

Review of current and emerging treatments for older adults with acute myeloid leukemia, highlighting venetoclax plus hypomethylating agents and future targeted therapy combinations in routine care.

Guidelines recommend older adults with newly diagnosed AML should be offered antileukemic therapy over best supportive care.

CAR7, has shown remarkable success in reversing an aggressive form of leukemia. This world-first treatment uses genetically ...

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...

The FDA approved Blincyto for patients aged one month and older with CD19-positive, Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia. The Food and Drug Administration ...

A small group of patients with an otherwise incurable form of T‑cell leukemia have seen their cancer driven into remission by ...

Phase 1b–2 trial evaluates the potential of CAR T-cell therapy obe-cel in relapsed or refractory B-cell ALL patients. Chimeric antigen receptor (CAR) T-cell therapy has shown promise in inducing ...

The seventh annual Lift Against Leukemia benefit powerlifting competition took place at Work Harder Gym in Little Rock, ...